Nanobots Therapeutics
6 known investors
Find your way into Nanobots Therapeutics
Sign up to see every warm intro you have to Nanobots Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanobots Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.
Founders & leadership
SS
Samuel SánchezSamuel Sánchez is an independent research group leader in nanoscience and the founder of Nanobots Therapeutics, a spin-off of ICREA and IBEC that develops the MotionTx platform to create nanobots designed to penetrate tissues and improve drug accumulation in target cells.
Investors · 6
Capital Celllisted by Capital CellBarcelona
How we know: Capital Cell's portfolio page · Not right? Tell us
ESADE BANreportedBarcelona
How we know: ibecbarcelona.eu · Not right? Tell us
Also in the syndicate · 3
ACCIÓ StartUp Capital programBStartup HealthleadProus Institute for Biomedical Research
Funding
SEC filings, press & company announcements- Undisclosed amountPre-Seed funding roundSep 2023
BStartup Health (lead), ACCIÓ StartUp Capital program, ESADE-BAN, Prous Institute for Biomedical Research
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Nanobots Therapeutics do?
- Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.
- Who founded Nanobots Therapeutics?
- Nanobots Therapeutics was founded by Samuel Sánchez.
- Who are Nanobots Therapeutics's investors?
- Nanobots Therapeutics's investors include BStartup, Capital Cell, ESADE BAN.


